vs
安捷伦科技（A）与NATURAL HEALTH TRENDS CORP（NHTC）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是NATURAL HEALTH TRENDS CORP的184.4倍（$1.8B vs $9.7M）。安捷伦科技净利率更高（17.0% vs -6.0%，领先23.0%）。安捷伦科技同比增速更快（7.0% vs -10.1%）。安捷伦科技自由现金流更多（$175.0M vs $-964.0K）。过去两年安捷伦科技的营收复合增速更高（6.9% vs -5.6%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Sword Health是一家数字医疗企业，专注开发针对肌肉骨骼疾病、骨盆健康与损伤预防的物理治疗方案。该企业2015年由Virgílio Bento与Márcio Colunas在葡萄牙创立，将人工智能融入护理模式，提供数字化物理治疗服务。截至2024年，Sword Health已开展国际化运营，在美国、爱尔兰与葡萄牙均设有办公室。
A vs NHTC — 直观对比
营收规模更大
A
是对方的184.4倍
$9.7M
营收增速更快
A
高出17.1%
-10.1%
净利率更高
A
高出23.0%
-6.0%
自由现金流更多
A
多$176.0M
$-964.0K
两年增速更快
A
近两年复合增速
-5.6%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $9.7M |
| 净利润 | $305.0M | $-588.0K |
| 毛利率 | 52.6% | 72.9% |
| 营业利润率 | 19.6% | -6.5% |
| 净利率 | 17.0% | -6.0% |
| 营收同比 | 7.0% | -10.1% |
| 净利润同比 | -4.1% | -434.1% |
| 每股收益（稀释后） | $1.07 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANHTC
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $9.7M | ||
| Q3 25 | $1.7B | $9.5M | ||
| Q2 25 | $1.7B | $9.8M | ||
| Q1 25 | $1.7B | $10.7M | ||
| Q4 24 | $1.7B | $10.8M | ||
| Q3 24 | $1.6B | $10.7M | ||
| Q2 24 | $1.6B | $10.5M |
净利润ANHTC
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $-588.0K | ||
| Q3 25 | $336.0M | $-431.0K | ||
| Q2 25 | $215.0M | $15.0K | ||
| Q1 25 | $318.0M | $122.0K | ||
| Q4 24 | $351.0M | $176.0K | ||
| Q3 24 | $282.0M | $35.0K | ||
| Q2 24 | $308.0M | $173.0K |
毛利率ANHTC
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | 72.9% | ||
| Q3 25 | 51.1% | 73.7% | ||
| Q2 25 | 51.9% | 73.9% | ||
| Q1 25 | 53.5% | 73.6% | ||
| Q4 24 | 53.9% | 74.2% | ||
| Q3 24 | 54.2% | 74.1% | ||
| Q2 24 | 54.4% | 74.2% |
营业利润率ANHTC
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | -6.5% | ||
| Q3 25 | 20.7% | -5.2% | ||
| Q2 25 | 18.0% | -3.4% | ||
| Q1 25 | 22.4% | -3.2% | ||
| Q4 24 | 24.0% | -3.9% | ||
| Q3 24 | 21.1% | -2.6% | ||
| Q2 24 | 23.1% | -2.3% |
净利率ANHTC
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | -6.0% | ||
| Q3 25 | 19.3% | -4.5% | ||
| Q2 25 | 12.9% | 0.2% | ||
| Q1 25 | 18.9% | 1.1% | ||
| Q4 24 | 20.6% | 1.6% | ||
| Q3 24 | 17.9% | 0.3% | ||
| Q2 24 | 19.6% | 1.7% |
每股收益（稀释后）ANHTC
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $-0.05 | ||
| Q3 25 | $1.18 | $-0.04 | ||
| Q2 25 | $0.75 | $0.00 | ||
| Q1 25 | $1.11 | $0.01 | ||
| Q4 24 | $1.23 | $0.01 | ||
| Q3 24 | $0.97 | $0.00 | ||
| Q2 24 | $1.05 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $28.9M |
| 总债务越低越好 | $3.0B | — |
| 股东权益账面价值 | $6.9B | $23.4M |
| 总资产 | $12.8B | $38.4M |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资ANHTC
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $28.9M | ||
| Q3 25 | $1.5B | $32.0M | ||
| Q2 25 | $1.5B | $34.2M | ||
| Q1 25 | $1.5B | $41.9M | ||
| Q4 24 | $1.3B | $43.9M | ||
| Q3 24 | $1.8B | $46.3M | ||
| Q2 24 | $1.7B | $48.7M |
总债务ANHTC
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益ANHTC
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $23.4M | ||
| Q3 25 | $6.4B | $26.1M | ||
| Q2 25 | $6.1B | $28.9M | ||
| Q1 25 | $6.0B | $30.9M | ||
| Q4 24 | $5.9B | $32.9M | ||
| Q3 24 | $5.9B | $35.3M | ||
| Q2 24 | $6.2B | $37.3M |
总资产ANHTC
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $38.4M | ||
| Q3 25 | $12.2B | $42.3M | ||
| Q2 25 | $12.2B | $45.2M | ||
| Q1 25 | $11.9B | $53.2M | ||
| Q4 24 | $11.8B | $55.4M | ||
| Q3 24 | $11.0B | $58.3M | ||
| Q2 24 | $10.9B | $61.5M |
负债/权益比ANHTC
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $-959.0K |
| 自由现金流经营现金流 - 资本支出 | $175.0M | $-964.0K |
| 自由现金流率自由现金流/营收 | 9.7% | -9.9% |
| 资本支出强度资本支出/营收 | 5.2% | 0.1% |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $993.0M | $-6.1M |
8季度趋势，按日历期对齐
经营现金流ANHTC
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $-959.0K | ||
| Q3 25 | $362.0M | $113.0K | ||
| Q2 25 | $221.0M | $-5.6M | ||
| Q1 25 | $431.0M | $484.0K | ||
| Q4 24 | $481.0M | $88.0K | ||
| Q3 24 | $452.0M | $-436.0K | ||
| Q2 24 | $333.0M | $-3.6M |
自由现金流ANHTC
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | $-964.0K | ||
| Q3 25 | $259.0M | $70.0K | ||
| Q2 25 | $107.0M | $-5.6M | ||
| Q1 25 | $334.0M | $468.0K | ||
| Q4 24 | $388.0M | $68.0K | ||
| Q3 24 | $360.0M | $-443.0K | ||
| Q2 24 | $230.0M | $-3.6M |
自由现金流率ANHTC
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | -9.9% | ||
| Q3 25 | 14.9% | 0.7% | ||
| Q2 25 | 6.4% | -57.5% | ||
| Q1 25 | 19.9% | 4.4% | ||
| Q4 24 | 22.8% | 0.6% | ||
| Q3 24 | 22.8% | -4.1% | ||
| Q2 24 | 14.6% | -34.2% |
资本支出强度ANHTC
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | 0.1% | ||
| Q3 25 | 5.9% | 0.5% | ||
| Q2 25 | 6.8% | 0.0% | ||
| Q1 25 | 5.8% | 0.1% | ||
| Q4 24 | 5.5% | 0.2% | ||
| Q3 24 | 5.8% | 0.1% | ||
| Q2 24 | 6.5% | 0.2% |
现金转化率ANHTC
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | -375.67× | ||
| Q1 25 | 1.36× | 3.97× | ||
| Q4 24 | 1.37× | 0.50× | ||
| Q3 24 | 1.60× | -12.46× | ||
| Q2 24 | 1.08× | -20.62× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
NHTC
暂无分部数据
